Home / Companies / Fox Chase Cancer Center IRB

Fox Chase Cancer Center IRB FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Fox Chase Cancer Center IRB has 0 FDA recalls, 2 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Fox Chase Cancer Center IRB" is on file.

What these totals cover: FDA records filed under the name "Fox Chase Cancer Center IRB".

Latest inspection: Sep 10, 2025 · NAI

Summary

Record counts and when each FDA source was last refreshed
Records	Count	Last refreshed	Source as of	Status
Recalls	0	Nov 8, 2026	File dated Nov 3, 2026	Current
510(k) clearances	0	Nov 8, 2026	File dated Nov 2, 2026	Current
Inspections	2	Nov 14, 2026	Newest record Nov 5, 2026	Current
Compliance actions	0	Nov 2, 2026	Newest record Oct 29, 2026	Current

FDA record by year

Fox Chase Cancer Center IRB's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Year	Inspections	OAI	Warning letters	Recall records	Class I
2026	0	0	0	0	0
2025	1	0	0	0	0
2024	0	0	0	0	0
2023	0	0	0	0	0
2022	0	0	0	0	0
2021	0	0	0	0	0
2020	0	0	0	0	0
2019	1	0	0	0	0
2018	0	0	0	0	0
2017	0	0	0	0	0

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Fox Chase Cancer Center IRB as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Fox Chase Cancer Center IRB yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

2 inspections from Feb 14, 2019 to Sep 10, 2025.

Date	Site	Product	Classification	FEI
Sep 10, 2025	Philadelphia, PA	Drugs	No Action Indicated (NAI)	2518761
Feb 14, 2019	Philadelphia, PA	Devices	No Action Indicated (NAI)	2518761

NAI: No objectionable conditions or practices were found during the inspection.
VAI: Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI: Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

Facility	Location	Inspections	Latest
FEI 2518761	Philadelphia, PA	2	Sep 10, 2025

Fox Chase Cancer Center IRB and the FDA: common questions

Has Fox Chase Cancer Center IRB received an FDA warning letter?

No FDA warning letter addressed to the name "Fox Chase Cancer Center IRB" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Fox Chase Cancer Center IRB received an FDA Form 483?

FDA has not published a Form 483 for "Fox Chase Cancer Center IRB" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Fox Chase Cancer Center IRB?

The most recent FDA inspection on file ended Sep 10, 2025 at Philadelphia, PA and was classified NAI. FDA has 2 inspections of Fox Chase Cancer Center IRB on file.

Need more than this page shows? Ask about Fox Chase Cancer Center IRB in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.